G‐quadruplex‐binding small molecules ameliorate <i>C9orf72</i> <scp>FTD</scp> / <scp>ALS</scp> pathology <i>in vitro</i> and <i>in vivo</i>
2017 · EMBO Molecular Medicine · 212 citations
https://doi.org/10.15252/emmm.201707850
A
Amanda Heslegrave
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
290
Papers
8.5K
Citations
55
h-index
136
i10-index
Amanda Heslegrave is an academic researcher from University College London. The author has contributed to research in topics: Alzheimer's disease research and treatments & Dementia and Cognitive Impairment Research & Genetic Neurodegenerative Diseases. The author has an h-index of 55, co-authored 247 publications.
ORCID: 0000-0002-7290-6405Papers by this author
worksHuman Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
2018 · Cell Reports · 163 citations
https://doi.org/10.1016/j.celrep.2018.07.094
Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta
2019 · Molecular Psychiatry · 152 citations
https://doi.org/10.1038/s41380-019-0410-8
Cerebrospinal fluid in the differential diagnosis of Alzheimer’s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic
2018 · Alzheimer s Research & Therapy · 128 citations
https://doi.org/10.1186/s13195-018-0361-3
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma
2019 · Experimental Gerontology · 122 citations
https://doi.org/10.1016/j.exger.2019.04.003
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease
2019 · Alzheimer s Research & Therapy · 102 citations
https://doi.org/10.1186/s13195-019-0472-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat